Today: 25 January 2026
Subscribe
Browse Category

NYSE:NVS News 11 January 2026 - 24 January 2026

Novartis stock near a year-high — what investors watch before earnings

Novartis stock near a year-high — what investors watch before earnings

Zurich, January 24, 2026, 20:57 CET — The market has closed. Novartis AG’s stock closed Friday at 115.64 Swiss francs, gaining 0.54 franc, or 0.47%. It swung between 114.70 and 116.04 during the session. Roughly 2.6 million shares traded hands. (Yahoo Finance) Novartis (NOVN.S) closed near the upper edge of its 52-week range, just shy of the 116.78 francs mark.…
24 January 2026
·····
Novartis stock set for holiday-thinned week after FDA breakthrough tag for Sjögren’s drug

Novartis stock set for holiday-thinned week after FDA breakthrough tag for Sjögren’s drug

ZURICH, Jan 17, 2026, 18:33 CET — Market closed. Novartis AG (NVS) shares ended Friday on a positive note after the Swiss pharma giant revealed that U.S. regulators awarded fast-track designation to its ianalumab programme. This move brings immunology back into focus ahead of the company’s earnings report. (MarketScreener) The FDA’s Breakthrough Therapy designation is designed to accelerate the development…
17 January 2026
····
Tempus AI stock pops 12% premarket after $1.1 billion contracts update — what traders watch next

Tempus AI stock pops 12% premarket after $1.1 billion contracts update — what traders watch next

New York, Jan 12, 2026, 07:52 EST — Premarket Tempus AI shares climbed roughly 12%, reaching $74.34 in Monday’s premarket session. (Investing) The bid emerged amid a volatile morning for growth stocks, with Nasdaq 100 futures slipping close to 1% as investors digested fresh doubts over the Federal Reserve’s independence and prepared for earnings season to begin. (Reuters) Tempus projected…
12 January 2026
··········
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

New York, Jan 12, 2026, 05:29 EST — Premarket Tempus AI, Inc. shares were up about 11% in premarket trading on Monday after the company flagged strong preliminary 2025 results and reported record contract value with drugmakers. Tempus AI traded at $73.66 in premarket action, after ending Friday at $66.27. (Google) The update lands as investors head into the annual…
12 January 2026
········
Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

Novartis stock on watch as Florida radioligand plant plan tees up JPM conference week

New York, January 11, 2026, 14:15 EST — Market closed. Novartis AG’s U.S.-listed shares (NVS) closed Friday mostly flat. Still, the stock starts the new week with a notable development: the company announced a new U.S. manufacturing facility for its radioligand cancer therapies. (Novartis) The timing matters because radioligand therapy demands tight logistics — every dose is tailored to a…
11 January 2026
····

Stock Market Today

  • Schaffer Corporation (ASX:SFC) Insiders Bolster Holdings to 46%, Signal Growth Confidence
    January 24, 2026, 6:42 PM EST. Insiders of Schaffer Corporation Limited (ASX:SFC) hold a substantial 46% stake, indicating strong vested interest in the company's future. The top five shareholders control about 51% of shares, consolidating significant influence. Recently, insiders have increased their share purchases, potentially signaling confidence in stock price appreciation. Institutional investors hold a notable but smaller stake, affirming some professional backing. CEO John Schaffer is the largest individual shareholder with 16% ownership, alongside key stakeholders Mutual Trust Pty Ltd and Blanka Schaffer, each holding 9.6%. Hedge funds show minimal involvement, and there is currently no analyst coverage, suggesting the stock remains under the radar. The insider activity and ownership concentration may impact Schaffer's upcoming market trajectory.
Go toTop